1.Surgical Perspective on Lung Cancer in 2024: Innovation and Challenges.
Pengxu KONG ; Xiaohan CHEN ; Wang LV ; Pinghui XIA ; Luming WANG ; Jian HU
Chinese Journal of Lung Cancer 2025;28(3):195-200
Lung cancer, a highly prevalent and deadly malignancy globally, poses a significant disease burden in China and is the leading cause of cancer death. Despite rapid advances in medicine, its incidence and mortality rates remain stubbornly high, making it a major challenge in public health. Against the backdrop of rapid progress in precision medicine, the paradigm of lung cancer treatment is shifting from single traditional therapy to multi-dimensional integration. This article comprehensively reviews the innovations and challenges in lung cancer surgery in 2024, aiming to explore the future development of surgical treatment with colleagues and to improve patients' quality of life and achieve the goal of "cure".
.
Humans
;
Lung Neoplasms/surgery*
2.Progress in hydrogel implantation in treatment of heart failure
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery 2022;29(04):502-507
Heart failure affects quality of life and life expectancy of tens of millions of individuals. There are no available economic and effective treatments for end-stage heart failure. Hydrogels are novel tissue engineering materials, which have the potential to ameliorate myocardium remodeling, increase cardiac output, improve quality of life and prolong life span by implantation into myocardium. The preclinical experiments and clinical trials have greatly explored the function of hydrogels in heart failure. In this review, we summarized the approaches of implantation, mechanism and clinical outcomes of the hydrogels.

Result Analysis
Print
Save
E-mail